Hospital Outpatient Drugs To Be Reimbursed ASP+8% Under Medicare In 2006
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS issues hospital Outpatient Prospective Payment System proposed rule for 2006. Reimbursement for specified covered outpatient drugs would be switched from the current 83% of average wholesale price to average sales price plus 8% in 2006; the rate includes ASP+6% for drug acquisition costs, plus 2% of ASP for "overhead" costs.
You may also be interested in...
J&J Files Antitrust Complaint Against Amgen For Aranesp Pricing Practice
Amgen's bundling of rebates for Aranesp, Neulasta and Neupogen have unfairly increased the anemia therapy's market share, the complaint alleges.
J&J Files Antitrust Complaint Against Amgen For Aranesp Pricing Practice
Amgen's bundling of rebates for Aranesp, Neulasta and Neupogen have unfairly increased the anemia therapy's market share, the complaint alleges.
MedPAC Recommends Outpatient Rx Handling Fee For Hospital Pharmacies
The Hospital Outpatient Prospective Payment System should include a payment adjustment for pharmaceutical handling costs, the Medicare Payment Advisory Committee recommended during an April 21 meeting in Washington, D.C